Electrophysiologic therapeutics in heart failure in adult congenital heart disease

Heart Fail Clin. 2014 Jan;10(1):69-89. doi: 10.1016/j.hfc.2013.09.011.

Abstract

Arrhythmias have long been recognized as a major cause of morbidity and mortality in the adult with congenital heart disease. It is important that the clinician accurately diagnoses these disturbances and is cognizant of the full array of antiarrhythmic agents and devices available to treat these conditions. This review discusses the most common arrhythmias encountered in this population and the therapeutic options available. Specific issues unique to this population are also addressed.

Keywords: Adult congenital heart disease; Antiarrhythmics; Arrhythmias; Device therapy; Electrophysiology; Heart failure; Resynchronization; Therapeutics.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adult
  • Anti-Arrhythmia Agents* / classification
  • Anti-Arrhythmia Agents* / therapeutic use
  • Arrhythmias, Cardiac* / diagnosis
  • Arrhythmias, Cardiac* / etiology
  • Arrhythmias, Cardiac* / therapy
  • Cardiac Surgical Procedures / methods
  • Catheter Ablation / adverse effects
  • Catheter Ablation / methods
  • Death, Sudden, Cardiac / etiology
  • Death, Sudden, Cardiac / prevention & control*
  • Defibrillators, Implantable / statistics & numerical data
  • Electrophysiologic Techniques, Cardiac* / instrumentation
  • Electrophysiologic Techniques, Cardiac* / methods
  • Heart Defects, Congenital / complications*
  • Heart Failure / complications*
  • Humans
  • Outcome and Process Assessment, Health Care
  • Pacemaker, Artificial / statistics & numerical data
  • Survival Analysis

Substances

  • Anti-Arrhythmia Agents